Tanya Brigden discusses the ethical implications and regulatory challenges that should be considered in the innovative area of genome editing. In recent years, the potential of somatic genome editing has elicited both excitement and caution among researchers, clinicians, patients, and ethicists.

Welcome back to Making science work for health, the PHG Foundation podcast that explains the most promising developments in science and their implications for healthcare.
 
In each episode, host Ofori Canacoo discusses with a PHG Foundation policy analyst, the underpinning science, the ambitions for improving population health and the impact it could have on patients, on society and on the people delivering your healthcare.
 
If you would like to find out more about what was discussed in this episode, you can find additional information on our website, phgfoundation.org.

Make sure to read our briefing on advanced therapy medicinal products as mentioned in the episode.

If you have any questions about the topic then you can email us at intelligence@phgfoundation.org.